Close

Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference

December 1, 2015 1:21 PM EST

BOULDER, Colo., Dec. 1, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

 

Event:         

Oppenheimer Annual Healthcare Conference

Presenter:    

Ron Squarer, Chief Executive Officer

Date:             

Wednesday, December 9, 2015

Time:             

10:20 a.m. Eastern Time

Webcast:    

http://www.veracast.com/webcasts/opco/healthcare2015/19204383745.cfm

 

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

 

CONTACT: 

Tricia Haugeto

Array BioPharma Inc.

303-386-1193

[email protected]

 

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-oppenheimer-annual-healthcare-conference-300186263.html

SOURCE Array BioPharma Inc.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases